AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...

Health Secretary Robert F. Kennedy Jr. is promoting his plan to “fix” the system that HHS uses to compensate people injured ...

Overview - The Centers for Medicare & Medicaid Services (“CMS”) has finalized and proposed several significant changes affecting ...

In this new study, investigators sought to measure and attribute out-of-pocket costs to cancer stage and by diagnosis.

A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in ...

The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

AstraZeneca ’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks ...

Markets only work when transparent prices reflect consumers' desires and the producers' costs. While there are complications, ...

Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

The Trump administration has gutted rules and programs meant to protect people from ever-increasing health care costs.

Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 3.7% in the morning session after the company ...